Libo Pharma Corp. (TPEX:7888)

Libo Pharma Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023
Period Ending	Jan 15, 2026	Dec 31, 2024	Dec 31, 2023
Debt / Equity Ratio	0.01	0.01	0.04
Quick Ratio	5.89	33.63	8.83
Current Ratio	6.38	35.39	9.12
Return on Equity (ROE)	-	-54.02%	-
Return on Assets (ROA)	-	-33.29%	-
Return on Capital Employed (ROCE)	-47.10%	-32.90%	-53.70%
Buyback Yield / Dilution	-	-41.35%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.